Ko M - Search Results

1

Crowdsourced identification of multi-target kinase inhibitors for RET- and TAU- based disease: The Multi-Targeting Drug DREAM Challenge.

Xiong Z, Jeon M, Allaway RJ, Kang J, Park D, Lee J, Jeon H, Ko M, Jiang H, Zheng M, Tan AC, Guo X; Multi-Targeting Drug DREAM Challenge Community; Dang KK, Tropsha A, Hecht C, Das TK, Carlson HA, Abagyan R, Guinney J, Schlessinger A, Cagan R. Xiong Z, et al. Among authors: ko m. PLoS Comput Biol. 2021 Sep 14;17(9):e1009302. doi: 10.1371/journal.pcbi.1009302. eCollection 2021 Sep. PLoS Comput Biol. 2021. PMID: 34520464 Free PMC article.

2

ReSimNet: drug response similarity prediction using Siamese neural networks.

Jeon M, Park D, Lee J, Jeon H, Ko M, Kim S, Choi Y, Tan AC, Kang J. Jeon M, et al. Among authors: ko m. Bioinformatics. 2019 Dec 15;35(24):5249-5256. doi: 10.1093/bioinformatics/btz411. Bioinformatics. 2019. PMID: 31116384

3

Chiral separation of beta-blockers after derivatization with (-)-alphamethoxy-alpha-(trifluoromethyl)phenylacetyl chloride by gas chromatography.

Kim KH, Lee JH, Ko MY, Hong SP, Youm JR. Kim KH, et al. Among authors: ko my. Arch Pharm Res. 2001 Oct;24(5):402-6. doi: 10.1007/BF02975183. Arch Pharm Res. 2001. PMID: 11693539

4

Determination of enantiomeric impurity of etodolac by capillary electrophoresis using (2-hydroxypropyl)-beta-cyclodextrin.

Dung PT, Ko MY, Choi HJ, Sin KS, Kim KH. Dung PT, et al. Arch Pharm Res. 2008 Sep;31(9):1218-23. doi: 10.1007/s12272-001-1292-4. Epub 2008 Sep 20. Arch Pharm Res. 2008. PMID: 18806967

5

Chiral separation of beta-blockers after derivatization with a new chiral derivatization agent, GATC.

Ko MY, Shin DH, Oh JW, Asegahegn WS, Kim KH. Ko MY, et al. Arch Pharm Res. 2006 Nov;29(11):1061-5. doi: 10.1007/BF02969292. Arch Pharm Res. 2006. PMID: 17146977

6

Longer travel times to acute hospitals are associated with lower likelihood of cancer screening receipt among rural-dwelling adults in the U.S. South.

Planey AM, Wong S, Planey DA, Winata F, Ko MJ. Planey AM, et al. Among authors: ko mj. Cancer Causes Control. 2024 Nov 22. doi: 10.1007/s10552-024-01940-x. Online ahead of print. Cancer Causes Control. 2024. PMID: 39576391

7

Halide-Diffusion-Assisted Perovskite Lamination Process for Semitransparent Perovskite Solar Cells.

Cheng J, Kim W, Choi I, Yu S, Koo B, Ko MJ. Cheng J, et al. Among authors: ko mj. Small. 2024 Nov 20:e2409821. doi: 10.1002/smll.202409821. Online ahead of print. Small. 2024. PMID: 39564739

8

Safety of the bivalent COVID-19 mRNA booster vaccination among persons aged over 18 years in the Republic of Korea.

Choi SK, Kim S, Ko M, Heo Y, Kim TE, Lee Y, Jang J, Bahng E. Choi SK, et al. Among authors: ko m. Osong Public Health Res Perspect. 2024 Oct 29. doi: 10.24171/j.phrp.2024.0194. Online ahead of print. Osong Public Health Res Perspect. 2024. PMID: 39557576 Free article.

9

Immunoglobulin G4-related spinal pachymeningitis: A case report.

Chae TS, Kim DS, Kim GW, Won YH, Ko MH, Park SH, Seo JH. Chae TS, et al. Among authors: ko mh. World J Clin Cases. 2024 Nov 16;12(32):6551-6558. doi: 10.12998/wjcc.v12.i32.6551. World J Clin Cases. 2024. PMID: 39554894 Free PMC article.

10

The Importance of an Interdisciplinary Approach in the Transition of At-Risk Patients From Hospital to Skilled Nursing Facilities: A Case Report.

Ko MY, Darouian N. Ko MY, et al. Cureus. 2024 Oct 16;16(10):e71629. doi: 10.7759/cureus.71629. eCollection 2024 Oct. Cureus. 2024. PMID: 39552972 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,067 results

Search Page

Filters